MANGILIPALLY, S.; LINGALA, D.; DUSA, J.; S, A. T.; BOGI, N.; AELUKA, R.; D, P. Regulatory Pathways for Generic Antiviral Drugs: ANDA Requirements in the USA Compared With BRICS. International Journal of Life Science and Pharma Research, [S. l.], v. 16, n. 3, p. 64–75, 2026. DOI: 10.22376/ijlpr.v16i3.2059. Disponível em: https://ijlpr.com/index.php/journal/article/view/2059. Acesso em: 19 nov. 2026.